Carl Pabo

Carl O. Pabo is considered a "world leader in issues involving the structure and design of DNA-binding protein."[1] He is now founder and president of Humanity 2050, a nonprofit institute. [2] [3]

Education

[4]

  • B.S. (summa cum laude) from Yale, Molecular Biophysics and Biochemistry in 1974
  • Ph.D. from Harvard, Biochemistry and Molecular Biology in 1980.

Career

Dr. Pabo has been a Professor at the Johns Hopkins University School of Medicine (1982-1991) and at the Massachusetts Institute of Technology (1991-2001) and an Investigator with the Howard Hughes Medical Institute (1986-2001).[5] He's been a Visiting Professor at Caltech, Stanford, Berkeley and Harvard.[6] At Caltech, he taught a course called “The World in 2050.” [7]

He was Chief Scientific Officer at Sangamo BioSciences from 2001–2003.[8]

In 2018, he founded Humanity 2050 to “to advocate a more comprehensive, coherent way of thinking about the human future.” [9] He also serves as a scientific advisor for NanoDimension. [10]

Awards, Honors

Pabo became a Guggenheim Fellow in 2005.[11] He is a member of the National Academy of Sciences[12] and of the American Academy of Arts and Sciences.[13]

He has also won the Protein Society Young Investigator Award and the Pfizer Award in enzymology.[14]

References
  1. Carl Pabo - Professor @ Johns Hopkins University School of Medicine
  2. Project Syndicate Bio
  3. Humanity 2050
  4. Protean Futures LLC
  5. Carl O. Pabo, PhD | HHMI.org
  6. Protean Futures
  7. NAS Member Bio
  8. Protean Futures
  9. Humanity 2050 Blog
  10. Carl O. Pabo resume
  11. "John Simon Guggenheim Foundation | All Fellows".
  12. NAS profile
  13. Protean Futures
  14. Four professors elected to NAS membership


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.